Baxter International starts cash tender offers for 2026 and 2027 notes

Rhea-AI Filing Summary

Baxter International Inc. announced that it has started cash tender offers for certain outstanding debt securities. The company is offering to purchase any and all of its 2.600% senior unsecured notes due 2026 and a portion of its 1.915% senior unsecured notes due 2027, for an aggregate purchase price of up to $300 million, an amount that may be increased, decreased or eliminated under the terms of its offer to purchase dated November 19, 2025. The tender offers are being made only under that offer to purchase and are subject to applicable securities and other laws in relevant jurisdictions.

Insights

Credit & Capital Structure Analyst

Baxter launches up to $300 million debt tender offers.

Baxter International Inc. has begun cash tender offers for any and all of its 2.600% senior unsecured notes due 2026 and a portion of its 1.915% senior unsecured notes due 2027. The company caps the aggregate purchase price at up to $300 million, with flexibility to adjust this amount under the offer terms.

Retiring or reducing these notes could adjust Baxter’s interest expense profile and debt maturity schedule, depending on how many holders participate. The structure, including an “any and all” offer for the 2026 notes and a partial offer for the 2027 notes, indicates a targeted approach to managing near- and medium-term obligations.

The actual impact on leverage, liquidity, and interest costs will depend on the final tendered amounts once the offer to purchase process, dated November 19, 2025, runs its course and results are disclosed in subsequent communications.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

0000010456FALSE00000104562025-11-192025-11-190000010456bax:CommonStock1.00PerValueMemberexch:XCHI2025-11-192025-11-190000010456bax:CommonStock1.00PerValueMemberexch:XNYS2025-11-192025-11-190000010456bax:GlobalNotes13Due2029Memberexch:XNYS2025-11-192025-11-19

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): November 19, 2025

Baxter International Inc. 

(Exact name of registrant as specified in its charter)

Delaware

(State or other jurisdiction

of incorporation)

1-4448						36-0781620
(Commission File Number)						(I.R.S. Employer Identification No.)

One Baxter Parkway, Deerfield, Illinois						60015
(Address of principal executive offices)						(Zip Code)

(224) 948-2000

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d 2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $1.00 par value

BAX (NYSE)

New York Stock Exchange

1.3% Global Notes due 2029

BAX 29

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):

☐ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act: ☐

Item 8.01 Other Events.

On November 19, 2025, Baxter International Inc. (the “Company”) issued a press release announcing the commencement of cash tender offers (each, a “Tender Offer” and together, the “Tender Offers”) of (i) any and all of its 2.600% senior unsecured notes due 2026 (the “2026 Notes”) and (ii) a portion of its 1.915% senior unsecured notes due 2027 (the “2027 Notes”) in an aggregate purchase price up to $300 million (which amount is subject to increase, decrease or elimination in accordance with the terms of the Company’s related offer to purchase (as discussed below), and together with the 2026 Notes, the “Notes”). A copy of the press release announcing the Tender Offers is attached as Exhibit 99.1 to this Current Report on Form 8-K and is hereby incorporated by reference herein.

This Current Report on Form 8-K, including the press release incorporated by reference, is neither an offer to sell nor a solicitation of offers to buy any Notes. The Tender Offers are being made only pursuant to the offer to purchase of the Company, dated November 19, 2025. The Tender Offers are not being made to holders of Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

99.1			Press Release Dated November 19, 2025
(104)			Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Baxter International Inc.

By:

/s/ Joel T. Grade

Name:

Joel T. Grade

Date: November 19, 2025

Title:

Executive Vice President and Chief Financial Officer

FAQ

What did Baxter International Inc. (BAX) announce on November 19, 2025?

On November 19, 2025, Baxter International Inc. announced the commencement of cash tender offers for certain of its outstanding senior unsecured notes, as described in its offer to purchase dated that day.

Which Baxter (BAX) notes are included in the new tender offers?

The tender offers cover any and all of Baxter's 2.600% senior unsecured notes due 2026 and a portion of its 1.915% senior unsecured notes due 2027.

What is the maximum aggregate purchase price for Baxter’s tender offers?

Baxter set an aggregate purchase price of up to $300 million for the tender offers, and this amount may be increased, decreased or eliminated in line with the terms of the offer to purchase.

Is Baxter’s 8-K filing itself an offer to buy or sell the notes?

No. The 8-K and related press release state that they are neither an offer to sell nor a solicitation of offers to buy any notes. The tender offers are made only pursuant to Baxter’s offer to purchase dated November 19, 2025.

Where can investors find the detailed terms of Baxter’s tender offers?

The detailed terms are set out in Baxter’s offer to purchase dated November 19, 2025, which governs the tender offers referenced in the 8-K and press release.

Are Baxter’s tender offers available in all jurisdictions?

No. The company states that the tender offers are not being made to holders of notes in any jurisdiction where making or accepting the offers would violate local securities, blue sky or other laws.